Thrombectomy Devices Market is estimated to reach USD 1.45 billion by 2022

Product Development and Commercialization are the Key Strategies Adopted by Market Players to Foster their Growth in the Global Thrombectomy Devices Market
The global thrombectomy devices market is estimated to reach USD 1.45 Billion by 2022; growing at a CAGR of 6.7% during the forecast period. The growing target patient population, ongoing technological advancements, favorable medical reimbursements, rising demand for minimally invasive thrombectomy procedures, and increasing healthcare expenditure across emerging markets are some key factors propelling the growth of this thrombectomy devices market.
The key players focused on various strategies such as product launches and enhancements; agreements and collaborations; strategic acquisitions; and expansions to increase their shares in the global thrombectomy devices market. Product launches & enhancements is the strategy adopted by major industry players to achieve the desired market growth during 2013-2017.
This strategy was adopted by Stryker Corporation (U.S.), Medtronic plc (Ireland), Boston Scientific Corporation (U.S.), Johnson & Johnson (U.S.), Terumo Corporation (Japan), Penumbra, Inc. (U.S.), Spectranetics Corporation (U.S.), Edwards Lifesciences Corporation (U.S.), Argon Medical Devices, Inc.
(U.S.), and Teleflex Incorporated (U.S.). Apart from product launches and enhancements, many prominent players also adopted agreements and collaborations as their key growth strategy to strengthen their market presence, enhance their R&D capabilities, and to expand their distribution networks to generate additional demand by sensitizing end users through an increase in availability of thrombectomy devices.
Stryker Corporation held the leading position in the market in 2016. The company offers its thrombectomy devices through the Neurotechnology & Spine segment.
For instance, in 2016, the company commercialized thrombectomy devices such as Trevo Provue retriever and Trevo XP ProVue retriever, the establishment of its European headquarters in Amsterdam (Netherlands), in 2015, and the acquisition of Trauson Holdings Company Limited (China) in 2013. These developments strengthened its R&D capabilities and expanded its product portfolio in the market.
Medtronic plc is one of the prominent players in the market, in 2016. The company has a strong foothold in the market with a broad range of thrombectomy products.
The company has a strong geographic presence across Asia-Pacific, Eastern Europe, Latin America, the Middle East & Africa, Central Asia, Western Europe, South Asia, and North America. To strengthen its current position and to gain a larger share in the market, the company aggressively focuses on growth strategies such as acquisitions and market expansions.
It commercialized thrombectomy devices such as the Solitaire stent retriever device in 2016 and Solitaire revascularization device in 2012.
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
Organization: 
Name: 
Mr. Shelly Singh
Contact Address: 
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
newsletter@marketsandmarkets.com 

Comments

Popular posts from this blog

Future of Remote Patient Monitoring Industry: Impact of Remote Patient Monitoring on Healthcare

Strategies Adopted by the Major Players in this Digital PCR Market

Sinus Dilation Devices Market Size And Share Report, 2027